H.R. 2340: Advancing Enrollment and Reducing Drug Costs Act
This legislation, known as the Advancing Enrollment and Reducing Drug Costs Act, aims to make changes to the Medicare program as it relates to certain Medicaid beneficiaries. The main points of the bill are as follows:
Automatic Qualification for Subsidies
The bill proposes to automatically qualify certain individuals who receive Medicaid benefits for premium and cost-sharing subsidies under Medicare Part D. Specifically:
- It targets individuals enrolled in Medicaid who are under specific income thresholds.
- Those who are not already eligible for other specific subsidy categories will be considered subsidy-eligible if they meet the criteria outlined in the bill.
- This change would ensure that individuals with incomes below 200 percent of the poverty level (based on their family size) are automatically deemed eligible for financial help with their Medicare prescription drug costs.
Eligibility Criteria
Individuals who qualify under this provision must meet the following conditions:
- They must be receiving medical assistance through a state Medicaid plan as of the day before they turn 65.
- They must fall below the specified income level (200 percent of the poverty line).
Implementation Timeline
The provisions of the bill are set to go into effect for plan years starting on or after January 1, 2027. This gives stakeholders time to adjust to the new requirements.
Purpose of the Legislation
The overall goal of this bill is to reduce the financial burden on qualifying low-income individuals who rely on both Medicaid and Medicare for their healthcare needs, particularly focusing on prescription drug costs. By streamlining the subsidy qualification process, the legislation seeks to improve access to affordable medications for vulnerable populations.
Relevant Companies
- UNH: UnitedHealth Group may see a change in their enrollment numbers as more individuals automatically qualify for Medicare Part D subsidies, potentially impacting their business strategies and services offered under these programs.
- CVS: CVS Health, which also operates within the pharmacy benefits and retail pharmacy space, may be affected by changes in prescription drug purchasing patterns as a result of increased subsidies and access for qualifying individuals.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
Date | Action |
---|---|
Mar. 25, 2025 | Introduced in House |
Mar. 25, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.